Cargando…
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
HPV-driven oropharyngeal cancers have significantly better survival rates than tobacco and alcohol induced head and neck cancers. As HPV-positive patients are younger, healthier and far more likely to survive their disease, long-term treatment side effects are becoming a major issue. This has led th...
Autores principales: | Mirghani, Haitham, Blanchard, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862680/ https://www.ncbi.nlm.nih.gov/pubmed/29594236 http://dx.doi.org/10.1016/j.ctro.2017.10.005 |
Ejemplares similares
-
The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015) -
Where Do We Stand?
Publicado: (1891) -
Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016) -
Current Melanoma Treatments: Where Do We Stand?
por: Moreira, Alvaro, et al.
Publicado: (2021)